Mousavi, S.M.; Hashemi, S.A.; Gholami, A.; Kalashgrani, M.Y.; Vijayakameswara Rao, N.; Omidifar, N.; Hsiao, W.W.-W.; Lai, C.W.; Chiang, W.-H.
Plasma-Enabled Smart Nanoexosome Platform as Emerging Immunopathogenesis for Clinical Viral Infection. Pharmaceutics 2022, 14, 1054.
https://doi.org/10.3390/pharmaceutics14051054
AMA Style
Mousavi SM, Hashemi SA, Gholami A, Kalashgrani MY, Vijayakameswara Rao N, Omidifar N, Hsiao WW-W, Lai CW, Chiang W-H.
Plasma-Enabled Smart Nanoexosome Platform as Emerging Immunopathogenesis for Clinical Viral Infection. Pharmaceutics. 2022; 14(5):1054.
https://doi.org/10.3390/pharmaceutics14051054
Chicago/Turabian Style
Mousavi, Seyyed Mojtaba, Seyyed Alireza Hashemi, Ahmad Gholami, Masoomeh Yari Kalashgrani, Neralla Vijayakameswara Rao, Navid Omidifar, Wesley Wei-Wen Hsiao, Chin Wei Lai, and Wei-Hung Chiang.
2022. "Plasma-Enabled Smart Nanoexosome Platform as Emerging Immunopathogenesis for Clinical Viral Infection" Pharmaceutics 14, no. 5: 1054.
https://doi.org/10.3390/pharmaceutics14051054
APA Style
Mousavi, S. M., Hashemi, S. A., Gholami, A., Kalashgrani, M. Y., Vijayakameswara Rao, N., Omidifar, N., Hsiao, W. W.-W., Lai, C. W., & Chiang, W.-H.
(2022). Plasma-Enabled Smart Nanoexosome Platform as Emerging Immunopathogenesis for Clinical Viral Infection. Pharmaceutics, 14(5), 1054.
https://doi.org/10.3390/pharmaceutics14051054